Comprehensive Peptide Database

In-depth information on peptides, mechanisms, and research applications

Table of Contents

GLP-1 Peptides

GLP-1 (Glucagon-Like Peptide-1) receptor agonists are peptides that activate the GLP-1 receptor, mimicking the action of the endogenous hormone GLP-1. These peptides have gained significant attention for their effects on glucose metabolism, appetite regulation, and weight management.

Semaglutide

Key Research Findings

  • Accelerated tendon healing in animal models
  • Reduced inflammation in various tissues
  • Protective effects on intestinal tissue
  • Potential to protect against certain drug toxicities

Molecular Structure

15-amino acid peptide derived from a protective protein found in gastric juice.

Half-life

Relatively short half-life, typically requiring once or twice daily administration.

TB-500 (Thymosin Beta-4)

Mechanism of Action

TB-500 is a synthetic version of the naturally occurring peptide Thymosin Beta-4. It promotes cell migration and proliferation, enhances angiogenesis, modulates inflammation, and upregulates actin, a protein essential for cell structure and movement.

Research Applications

  • Soft tissue repair
  • Wound healing
  • Inflammation reduction
  • Cardiac tissue protection

Research Dosage Range

Typically studied at 2-5mg twice weekly for 4-6 weeks, followed by a maintenance phase.

Key Research Findings

  • Increased blood vessel formation in wound sites
  • Improved flexibility in tendons and ligaments
  • Cardiac protective effects in animal models
  • Potentially accelerated recovery from tissue damage

Molecular Structure

43-amino acid peptide that is a synthetic fragment of the protein thymosin beta-4.

Half-life

Short half-life of several hours, though its effects may persist longer due to its mechanism of action.

Cognitive & Neuroprotective Peptides

Cognitive and neuroprotective peptides are compounds that may support brain health, enhance cognitive function, or provide protective effects for neurons. These peptides are of interest in aging research and neurodegenerative disease studies.

Semax

Mechanism of Action

Semax is a synthetic peptide derived from ACTH (adrenocorticotropic hormone). It modulates the expression of brain-derived neurotrophic factor (BDNF) and other neurotrophic factors, enhances dopamine and serotonin metabolism, and has neuroprotective properties.

Research Applications

  • Cognitive enhancement
  • Neuroprotection
  • Stress resistance
  • Stroke recovery research

Research Dosage Range

Typically studied at 300-1200mcg daily, administered intranasally or subcutaneously.

Key Research Findings

  • Enhanced memory and learning in experimental models
  • Neuroprotective effects in ischemia models
  • Increased BDNF levels in the brain
  • Potential anxiolytic effects

Molecular Structure

Heptapeptide with the sequence Met-Glu-His-Phe-Pro-Gly-Pro, corresponding to ACTH(4-10).

Half-life

Relatively short half-life, though intranasal administration may prolong its effects in the CNS.

Selank

Mechanism of Action

Selank is a synthetic peptide based on the human tetrapeptide tuftsin with an added stabilizing sequence. It modulates the expression of BDNF, affects serotonin systems, and interacts with GABA neurotransmission.

Research Applications

  • Anxiety reduction
  • Cognitive enhancement
  • Immune modulation
  • Stress resilience

Research Dosage Range

Typically studied at 300-900mcg daily, administered intranasally.

Key Research Findings

  • Anxiolytic effects without sedation
  • Potential cognitive enhancement in some models
  • Stabilization of enkephalins in the body
  • Immune-boosting properties

Molecular Structure

Heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro, based on the immunomodulatory peptide tuftsin.

Half-life

Relatively short half-life, though intranasal administration provides direct access to the CNS.

SS-31 (Elamipretide)

Mechanism of Action

SS-31 is a mitochondria-targeted peptide that binds to cardiolipin in the inner mitochondrial membrane. It helps stabilize mitochondrial cristae, improves electron transport chain efficiency, reduces reactive oxygen species production, and enhances ATP synthesis.

Research Applications

  • Mitochondrial function enhancement
  • Neurodegenerative disease research
  • Cardioprotection
  • Age-related diseases

Research Dosage Range

Typically studied at 4-40mg daily in human clinical trials.

Key Research Findings

  • Improved mitochondrial function in various tissues
  • Reduced oxidative stress in experimental models
  • Potential benefits in age-related macular degeneration
  • Protective effects in models of neurodegenerative disease

Molecular Structure

Tetrapeptide with the sequence D-Arg-dimethylTyr-Lys-Phe-NH2, designed to target and concentrate in mitochondria.

Half-life

Short half-life in circulation, though its mitochondrial targeting properties may prolong its effects at the cellular level.

Immune System Peptides

Immune system peptides are compounds that modulate immune function, including thymic peptides that help regulate T-cell development and function. These peptides are researched for their potential in supporting immune health and addressing immune-related conditions.

Thymalin

Mechanism of Action

Thymalin is a polypeptide complex isolated from the thymus gland. It regulates T-cell differentiation and function, stimulates immune response, and modulates cytokine production.

Research Applications

  • Immune system support
  • Age-related immune decline
  • Infection resistance
  • Inflammatory conditions

Research Dosage Range

Typically studied at 5-20mg administered every 3-7 days.

Key Research Findings

  • Increased T-lymphocyte counts in some studies
  • Restored thymic function in aging models
  • Potential benefits in recovery from infections
  • Immunomodulatory effects without overstimulation

Molecular Structure

Complex mixture of peptides isolated from the thymus with molecular weights of approximately 5-10 kDa.

Half-life

Variable half-life, though effects may persist for several days due to its mechanism of action.

Common Protocols & Combinations

Many research protocols utilize combinations of peptides to achieve synergistic effects. Below are some common combinations studied in research settings:

GLP-1 + Amylin

The combination of GLP-1 receptor agonists (semaglutide, tirzepatide) with amylin analogs (cagrilintide) is being studied for potentially enhanced weight loss effects through complementary mechanisms of action.

CJC-1295 + Ipamorelin

This combination utilizes the synergistic effects of a GHRH analog (CJC-1295) with a ghrelin mimetic (Ipamorelin) to potentially enhance growth hormone release beyond what either peptide might achieve alone.

BPC-157 + TB-500

These recovery peptides are often researched together for their complementary mechanisms in supporting tissue repair, with BPC-157 providing localized healing effects and TB-500 promoting systemic recovery and angiogenesis.

Semax + Selank

This cognitive enhancement combination pairs the more stimulating and focus-enhancing properties of Semax with the anxiolytic and stress-reducing effects of Selank.

Preparation & Storage

Proper preparation and storage are crucial for maintaining peptide stability and efficacy in research settings. Here are general guidelines for handling peptides:

Reconstitution

  • Use bacteriostatic water (0.9% benzyl alcohol) for most peptides
  • Some peptides may require specific diluents (sterile water, acetic acid solution)
  • Gently swirl vial to dissolve - never shake vigorously
  • Allow peptide to fully dissolve before use
  • Calculate concentration using our Peptide Calculator

Storage - Lyophilized (Powder)

  • Store in freezer (-20°C) for long-term storage
  • Most lyophilized peptides stable for 2+ years when stored properly
  • Protect from light, heat, and moisture
  • Allow to reach room temperature before opening to prevent moisture condensation

Storage - Reconstituted

  • Store in refrigerator (2-8°C) for most peptides
  • Typical stability is 2-4 weeks when refrigerated
  • Some peptides (especially GHRPs) may require freezing even after reconstitution
  • Avoid repeated freeze-thaw cycles
  • Protect from light

Handling Tips

  • Use sterile technique when reconstituting and drawing peptides
  • Wipe vial tops with alcohol swab before insertion
  • Use new sterile syringe and needle for each procedure
  • Insulin syringes (29-31G) are typically used for measurement
  • Discard any discolored or cloudy solutions

Important Disclaimer

All peptides sold on this website are for research purposes only. They are not intended for human consumption, veterinary use, or as medical products. These products are not intended to diagnose, treat, cure, or prevent any disease. The information provided on this website is for educational purposes only and should not be considered medical advice. Always consult with a licensed healthcare professional before starting any new health program.

d text-gray-700">Mechanism of Action

Semaglutide is a GLP-1 receptor agonist that stimulates insulin secretion and inhibits glucagon secretion in a glucose-dependent manner. It slows gastric emptying and reduces appetite through central mechanisms.

Research Applications

Research Dosage Range

Studies typically use 0.25mg to 2.4mg weekly, with titration starting at lower doses.

Key Research Findings

Molecular Structure

Modified GLP-1 analog with 94% sequence homology to human GLP-1, with a C18 fatty diacid chain attached to lysine at position 26 via a spacer.

Half-life

Approximately 1 week, allowing for weekly dosing.

Tirzepatide

Mechanism of Action

Tirzepatide is a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptor agonist. It activates both the GIP and GLP-1 receptors, enhancing insulin secretion, reducing glucagon secretion, slowing gastric emptying, and increasing satiety.

Research Applications

  • Type 2 diabetes management
  • Weight management
  • Cardiovascular health
  • NASH and metabolic syndrome

Research Dosage Range

Studies typically use 5mg to 15mg weekly, with titration starting at lower doses.

Key Research Findings

  • Superior glycemic control compared to semaglutide in head-to-head trials
  • Average weight loss of 20-22% of body weight in some trials
  • Significant improvements in lipid profiles
  • Reduction in liver fat content

Molecular Structure

39-amino acid synthetic linear peptide with a C20 fatty diacid chain that enables albumin binding, prolonging its half-life.

Half-life

Approximately 5 days, allowing for weekly dosing.

Retatrutide

Mechanism of Action

Retatrutide is a triple receptor agonist that activates GLP-1, GIP, and glucagon receptors. This trimodal action enhances insulin secretion, reduces appetite, increases energy expenditure, and improves lipid metabolism.

Research Applications

  • Obesity management
  • Type 2 diabetes
  • Metabolic syndrome
  • NASH and liver health

Research Dosage Range

Recent studies have investigated doses from 1mg to 12mg weekly.

Key Research Findings

  • Weight loss of up to 24% in phase 2 trials
  • Significant reduction in waist circumference
  • Improvements in liver enzymes and metabolic markers
  • Potentially superior weight loss compared to tirzepatide

Molecular Structure

Novel synthetic peptide with modifications that allow activation of three different receptors (GLP-1, GIP, and glucagon).

Half-life

Designed for weekly administration with a half-life of approximately 5-6 days.

Cagrilintide

Mechanism of Action

Cagrilintide is a long-acting amylin analog that activates amylin receptors. It slows gastric emptying, reduces food intake, and induces satiety through central mechanisms distinct from GLP-1.

Research Applications

  • Weight management
  • Obesity research
  • Combination therapy with GLP-1 agonists

Research Dosage Range

Studies have investigated doses from 0.3mg to 4.5mg weekly.

Key Research Findings

  • Dose-dependent weight loss
  • Additive weight loss effects when combined with semaglutide
  • Well-tolerated with minimal GI side effects

Molecular Structure

Modified human amylin analog with an albumin-binding acyl group that extends half-life.

Half-life

Extended half-life of approximately 7 days, allowing for weekly dosing.

Mazdutide

Mechanism of Action

Mazdutide is a dual GLP-1 and glucagon receptor agonist. It enhances insulin secretion and increases satiety through GLP-1 activity while promoting energy expenditure and lipolysis through glucagon activity.

Research Applications

  • Obesity management
  • Type 2 diabetes
  • NASH and fatty liver disease
  • Metabolic syndrome

Research Dosage Range

Phase 2 studies have evaluated doses from 3mg to 9mg weekly.

Key Research Findings

  • Significant weight loss of up to 18-20% in clinical studies
  • Improvement in glycemic control
  • Reduction in liver fat content
  • Potentially increased metabolic rate compared to GLP-1-only agonists

Molecular Structure

Synthetic peptide designed to activate both GLP-1 and glucagon receptors with balanced potency.

Half-life

Designed for weekly administration with a half-life of approximately 5 days.

Growth Hormone Peptides

Growth hormone peptides are compounds that either stimulate the release of growth hormone from the pituitary gland or mimic certain effects of growth hormone in the body. These peptides are researched for their potential effects on body composition, recovery, and anti-aging properties.

Tesamorelin

Mechanism of Action

Tesamorelin is a growth hormone-releasing hormone (GHRH) analog that stimulates the pituitary gland to release growth hormone. It mimics the action of endogenous GHRH with enhanced stability and potency.

Research Applications

  • Reduction of visceral adipose tissue
  • Metabolic health research
  • Body composition changes
  • Cognitive function

Research Dosage Range

Typically studied at 1-2mg daily for subcutaneous administration.

Key Research Findings

  • Significant reduction in visceral fat in clinical trials
  • Improved lipid profiles
  • Increased IGF-1 levels
  • Potential cognitive benefits in early research

Molecular Structure

44-amino acid synthetic analog of human GHRH with a trans-3-hexenoic acid group that enhances stability.

Half-life

Approximately 4 hours, requiring daily administration.

Ipamorelin

Mechanism of Action

Ipamorelin is a selective growth hormone secretagogue that stimulates growth hormone release by binding to the ghrelin receptor (GHSR-1a) in the pituitary. Unlike other GH secretagogues, it does not significantly affect cortisol, prolactin, or other hormones.

Research Applications

  • Body composition research
  • Recovery and repair
  • Sleep quality studies
  • Anti-aging research

Research Dosage Range

Typically studied at 200-300mcg 1-3 times daily.

Key Research Findings

  • Selective growth hormone release without affecting other hormones
  • Minimal impact on cortisol levels
  • Enhanced fat metabolism in animal studies
  • Potential improvement in sleep quality

Molecular Structure

Pentapeptide ghrelin mimetic with the sequence Aib-His-D-2-Nal-D-Phe-Lys-NH2.

Half-life

Approximately 2 hours, typically requiring multiple daily administrations.

MOD-GRF 1-29 (CJC-1295 without DAC)

Mechanism of Action

MOD-GRF 1-29 is a modified form of growth hormone-releasing hormone (GHRH) that stimulates the pituitary gland to release growth hormone. It is a modified version of the first 29 amino acids of GHRH with enhanced stability.

Research Applications

  • Growth hormone secretion studies
  • Body composition research
  • Anti-aging studies
  • Often combined with GH secretagogues like ipamorelin

Research Dosage Range

Typically studied at 100-200mcg 1-3 times daily.

Key Research Findings

  • Creates a more pulsatile release of GH compared to CJC-1295 with DAC
  • Synergistic effects when combined with GHRPs
  • May improve sleep quality
  • Enhanced recovery in some research models

Molecular Structure

Modified version of the first 29 amino acids of GHRH with substitutions that increase stability and resistance to enzymatic degradation.

Half-life

Approximately 30 minutes, requiring multiple daily administrations.

Healing & Recovery Peptides

Healing and recovery peptides are researched for their potential to accelerate tissue repair, reduce inflammation, and support regenerative processes. These peptides are of interest in various applications including sports medicine, aging, and chronic injury research.

BPC-157

Mechanism of Action

BPC-157 (Body Protection Compound-157) is derived from a protective protein found in gastric juice. It promotes angiogenesis, accelerates wound healing, and has anti-inflammatory effects. It may interact with growth hormone and IGF-1 pathways and modulate nitric oxide production.

Research Applications

  • Tendon and ligament healing
  • Muscle recovery
  • Gastrointestinal repair
  • Neuroprotection

Research Dosage Range

Typically studied at 250-500mcg daily, administered either subcutaneously or orally.